AVL and Boehringer link up in hospital point of care
This article was originally published in Clinica
Swiss company AVL Medical Instruments and Boehringer Mannheim have formed an R&D, manufacturing and co-marketing agreement for productions and services in the hospital point-of-care market. The two companies plan to offer integrated information management as well as product solutions.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.